Bone Marrow TransplantationCyclophosphamideBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseTransplantation, AutologousAntineoplastic Combined Chemotherapy ProtocolsWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationAnemia, AplasticTransplantation ConditioningLeukemiaBusulfanCombined Modality TherapyTransplantation ChimeraBone Marrow PurgingGraft SurvivalLiver TransplantationHematopoietic Stem CellsBone Marrow DiseasesTissue DonorsTreatment OutcomeHistocompatibility TestingHistocompatibilityHematopoiesisBone Marrow ExaminationRecurrenceImmunosuppressive AgentsTransplantation, IsogeneicTime FactorsMice, Inbred C57BLRemission InductionLeukemia, Myeloid, AcuteLymphoma, Non-HodgkinSurvival AnalysisBone Marrow NeoplasmsKidney TransplantationRadiation ChimeraEtoposideDoxorubicinPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveChemotherapy, AdjuvantDisease-Free SurvivalHematologic NeoplasmsImmunosuppressionLeukemia, MyeloidSurvival RateHepatic Veno-Occlusive DiseaseGraft RejectionMethotrexateColony-Forming Units AssayGranulocyte Colony-Stimulating FactorGraft vs Host ReactionStem Cell TransplantationCarmustineAcute DiseaseLymphocyte DepletionTransplantation ImmunologyBone RemodelingVincristineFollow-Up StudiesCytarabineMyelodysplastic SyndromesAntineoplastic Agents, AlkylatingT-LymphocytesHematologic DiseasesActuarial AnalysisPrognosisMelphalanAntineoplastic AgentsLeukocyte TransfusionLeukocyte CountRetrospective StudiesChimeraHeart TransplantationSevere Combined ImmunodeficiencyHLA AntigensSpleenCyclosporineMultiple MyelomaPrednisonePancytopeniaLymphomaDrug Administration ScheduleCell DifferentiationLymphocyte TransfusionHodgkin DiseaseMice, Inbred BALB CFlow CytometryLung TransplantationBone DensityAntigens, CD34Nuclear FamilyAntibodies, MonoclonalGraft vs Tumor EffectCells, CulturedThiotepa